Xtant Medical Holdings Inc represents a commitment to improving patient lives through innovative medical solutions. With a focus on regenerative medicine products and services, Xtant Medical aims to empower surgeons and healthcare professionals to provide better outcomes for their patients. Emphasizing excellence, quality, and integrity, the company is dedicated to delivering state-of-the-art medical technologies that address complex spinal and orthopedic conditions. By leveraging cutting-edge research, clinical expertise, and advanced manufacturing capabilities, Xtant Medical strives to meet the evolving needs of patients, surgeons, and healthcare providers.

Xtant Medical Holdings Inc is primarily present in the United States.

Xtant Medical Holdings Inc has achieved significant milestones in its journey. The company has successfully expanded its product portfolio and established a strong presence in the medical industry. Xtant Medical Holdings Inc has consistently delivered innovative solutions and advanced technologies to provide better patient care. With its dedication to research and development, the company has introduced a range of groundbreaking products for spinal fusion and orthopedic surgeries. Xtant Medical Holdings Inc has also expanded its market reach by forming strategic partnerships and collaborations. These milestones demonstrate the company's commitment to advancing medical solutions and improving patient outcomes.

Xtant Medical Holdings Inc, a leading medical technology company, has a rich history and background. Founded in 2013, Xtant Medical specializes in the development, production, and commercialization of regenerative medicine products and implants that are used for orthopedic and neurological procedures. The company focuses on providing innovative solutions to enhance the healing and tissue regeneration process. Xtant Medical has an extensive product portfolio that includes bone grafts, spinal implants, and biologics. With a dedication to quality and patient outcomes, Xtant Medical has gained a strong presence in the industry, delivering advanced medical solutions to healthcare professionals and patients worldwide.

The main competitors of Xtant Medical Holdings Inc in the market include Medtronic, Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc, and Globus Medical Inc.

Xtant Medical Holdings Inc is primarily active in the medical device and biotechnology industries.

The business model of Xtant Medical Holdings Inc, a leading medical device company, focuses on developing, manufacturing, and commercializing innovative regenerative medicine products for orthopedic and neurological conditions. Xtant Medical Holdings Inc aims to enhance patient care and improve clinical outcomes through their extensive portfolio, which includes a range of biologics, implants, and instruments. By leveraging advanced technologies and strategic partnerships, Xtant Medical Holdings Inc strives to provide healthcare professionals with cutting-edge solutions to address the unmet needs of patients suffering from various musculoskeletal disorders and injuries. Please note that this answer has been optimized for SEO purposes, incorporating the company name, Xtant Medical Holdings Inc, throughout the response.

Xtant Medical Holdings KGV ir -8,81.

Xtant Medical Holdings KUV ir 0,78.

AlleAktien kvalitātes vērtējums Xtant Medical Holdings ir 5/10.

gaidāmā Xtant Medical Holdings apgrozījums ir 120,41 milj. USD.

gaidāmā Xtant Medical Holdings peļņa ir -10,63 milj. USD.

Xtant Medical Holdings Inc. is a company specializing in the manufacture and distribution of orthopedic implants and biological products for the human body. The company is headquartered in Belgrade, Montana, USA and has branches in various regions, including Europe, Asia, and the Middle East. The business model of Xtant Medical is divided into two parts. Firstly, the company offers orthopedic implants such as knee, hip, and spinal supplements. Secondly, the company produces bone grafts and biological products that can promote bone growth. The company aims to produce a comprehensive range of high-quality medical implants and biological products that meet the diverse needs of patients worldwide. The implants and biological products are developed and manufactured by experienced surgeons and professionals to ensure the highest quality and safety. Xtant Medical also operates its own research and development department to continuously improve its products and develop new ones. A strong sales and marketing department is also present to acquire new customers and strengthen existing customer relationships. The company follows a multi-channel distribution strategy and works with distributors, sales partners, and direct sales teams. Some of Xtant Medical's main products include knee, hip, and spinal supplements. These implants are designed to improve the mobility and quality of life for patients. The implants are made of high-quality materials such as titanium, polyethylene, and ceramic and are available in different sizes to meet the individual needs of each patient. The company also produces a wide range of biological products that can promote bone growth. These products include bone grafts, synthetic bone substitutes, and growth factors. These products are used to repair and regenerate bones in various parts of the body. In addition to these products, Xtant Medical also offers various services, including training and education for surgeons, technical support, and customized solutions. Overall, Xtant Medical has a diversified business model that targets the needs of patients in different regions of the world. The company has a strong research and development department to continuously improve its products and operates a multi-channel distribution strategy to expand its customer base. With high-quality implants and biological products, as well as reliable customer service, Xtant Medical has established itself as one of the leading companies in the orthopedic industry.

Xtant Medical Holdings izmaksā dividendes 0 USD, kas tiek izmaksātas reizes gadā.

Dividendes pašlaik nevar aprēķināt Xtant Medical Holdings vai uzņēmums nedod dividendes.

Xtant Medical Holdings ISIN ir US98420P3082.

Xtant Medical Holdings WKN ir A2JDJS.

Xtant Medical Holdings simbols ir XTNT.

Pēdējo 12 mēnešu laikā Xtant Medical Holdings maksāja dividendes apmērā. Tas atbilst aptuveni dividendes ražībai. Nākamajos 12 mēnešos Xtant Medical Holdings plāno maksāt dividendes 0 USD apmērā.

Xtant Medical Holdings pašreizējā dividendu rentabilitāte ir .

Xtant Medical Holdings maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos .

Xtant Medical Holdings pēdējo 0 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 0 USD. Tas atbilst dividendes ražībai 0 %.

Xtant Medical Holdings tiek piešķirts nozarei "Veselība".

Lai saņemtu pēdējo dividendu Xtant Medical Holdings apmērā 0 USD, kas tika izmaksāta 28.07.2024., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 28.07.2024..

Pēdējās dividendes izmaksa notika 28.07.2024..

Gadā 2023, Xtant Medical Holdings izmaksāja 0 USD dividendes.

Xtant Medical Holdings dividendes tiek izmaksātas USD.